Bihua Chen's most recent trade in BridgeBio Oncology Therapeutics Inc. was a trade of 5,598,425 Common Stock done at an average price of $10.7 . Disclosure was reported to the exchange on Aug. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Oncology | Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.72 per share. | 11 Aug 2025 | 5,598,425 | 5,667,785 | - | 10.7 | 60,000,000 | Common Stock |
| BridgeBio Oncology | Bihua Chen | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 4,172,126 | 4,681,126 | - | - | Common Stock | |
| BridgeBio Oncology | Bihua Chen | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 4,172,126 | 0 | - | - | Class B ordinary shares | |
| BridgeBio Oncology | Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2025 | 1,905,046 | 1,905,046 | - | - | Common Stock | |
| BridgeBio Oncology | Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2025 | 1,762,760 | 3,305,470 | - | - | Common Stock | |
| BridgeBio Oncology | Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.72 per share. | 11 Aug 2025 | 760,496 | 2,187,536 | - | 10.7 | 8,150,464 | Common Stock |
| BridgeBio Oncology | Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.72 per share. | 11 Aug 2025 | 639,110 | 1,542,710 | - | 10.7 | 6,849,534 | Common Stock |
| BridgeBio Oncology | Bihua Chen | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Aug 2025 | 307,874 | 4,172,126 | - | - | Class B ordinary shares | |
| BridgeBio Oncology | Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2025 | 284,571 | 5,952,356 | - | - | Common Stock | |
| BridgeBio Oncology | Bihua Chen | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Aug 2025 | 152,940 | 4,528,186 | - | 0 | Common Stock | |
| Biomea Fusion Inc | Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 91,970 | 91,970 | - | - | Stock Option (Right to Buy) | |
| Helix Acquisition Corp II | Bihua Chen | Director, CEO and Chairperson, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 08 Feb 2025 | 30,000 | 4,480,000 | - | - | Class B Ordinary Shares | |
| Biomea Fusion Inc | Bihua Chen | Director, Ten Percent Owner | 12 Jun 2024 | 51,025 | 51 | - | - | Stock Option (right to buy) | ||
| Erasca Inc | Bihua Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Biomea Fusion Inc | Bihua Chen | Director, Ten Percent Owner | 30 Mar 2023 | 400,000 | 3,570,872 | - | 30 | 12,000,000 | Common Stock | |
| Erasca Inc | Bihua Chen | Director | Purchase of securities on an exchange or from another person at price $ 6.50 per share. | 13 Dec 2022 | 307,692 | 10,813,246 | - | 6.5 | 1,999,998 | Common Stock |
| Erasca Inc | Bihua Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Biomea Fusion Inc | Bihua Chen | Director, Ten Percent Owner | 22 Jun 2022 | 23,867 | 23,867 | - | - | Stock Option (right to buy) | ||
| Erasca Inc | Bihua Chen | Director | Sale of securities on an exchange or to another person at price $ 18.76 per share. | 26 Jul 2021 | 200,000 | 10,305,553 | - | 18.8 | 3,753,000 | Common Stock |
| Erasca Inc | Bihua Chen | Director | Purchase of securities on an exchange or from another person at price $ 22.10 per share. | 26 Jul 2021 | 200,000 | 10,505,553 | - | 22.1 | 4,420,000 | Common Stock |
| Erasca Inc | Bihua Chen | Director | 20 Jul 2021 | 9,555,553 | 9,555,553 | - | - | Common Stock | ||
| Erasca Inc | Bihua Chen | Director | 20 Jul 2021 | 4,166,666 | 0 | - | - | Series B-1 Convertible Preferred Stock | ||
| Erasca Inc | Bihua Chen | Director | 20 Jul 2021 | 4,000,000 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Erasca Inc | Bihua Chen | Director | 20 Jul 2021 | 1,388,887 | 0 | - | - | Series B-2 Convertible Preferred Stock | ||
| Erasca Inc | Bihua Chen | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 20 Jul 2021 | 950,000 | 10,505,553 | - | 16 | 15,200,000 | Common Stock |
| Biomea Fusion Inc | Bihua Chen | Director | 20 Apr 2021 | 2,270,872 | 2,270,872 | - | - | Common Stock | ||
| Biomea Fusion Inc | Bihua Chen | Director | 20 Apr 2021 | 2,270,872 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Biomea Fusion Inc | Bihua Chen | Director | 20 Apr 2021 | 900,000 | 3,170,872 | - | 17 | 15,300,000 | Common Stock |